Tuesday, November 17, 2026

MEN'S HEALTH: Thermal Imaging of the Chest

The Science and Clinical Interpretation of Thoracic Infrared Thermology

Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment, and the Potential Role of Functional Imaging in Male Breast Cancer Evaluation

Educational analysis of actual reports interpreted by Dr. Phil Hoekstra, DABT 


Introduction: Understanding What the Human Eye Cannot See

Medical infrared thermology examines patterns, levels and behavior of heat emitted from the body’s surface. Unlike mammography, ultrasound, or MRI, which principally depict anatomical features, thermography reveals skin-surface thermal features that reflect superficial blood flow, autonomic regulation, and other physiological influences. The distinction is important: a thermal image does not directly show a tumor or identify malignant cells.

Men’s breast health deserves greater clinical and public attention. Although male breast cancer is uncommon, men may overlook breast or nipple changes or delay seeking evaluation. Two anonymized thoracic examinations interpreted by Dr. Phil Hoekstra illustrate how the laboratory measures and classifies thermal patterns across the male chest. One report describes a persistent abnormal (TH-4, see below) pattern on one side; the other describes normal (TH-1, see below) findings. These reports offer useful examples of objective patho-physiological documentation, not evidence that thermography is an effective standalone screening test for male breast cancer.

How the Technology Identifies and Reads Thermal Patterns: Infrared cameras detect infrared energy emitted by the skin and convert it into quantitative surface-temperature measurements. There is no objective color to infrared energy so calibrated color palettes are software generated enabling an intuitive association of warmer and cooler colors that will correspond to temperature ranges on each image’s scale, not to particular diseases. Both reports include anterior and lateral views, temperature reference points, and replicate imaging sets. The interpreter considers regional symmetry, focal thermal differences, the configuration and extent of superficial vascular patterns, the distribution of thermal emissions and the adaptive response of the emission levels to a physiologic challenge.

click to enlarge

A valuable distinction is between what the instrument measures and what the clinician infers. The camera measures surface infrared emission; descriptions such as hyperthermia, asymmetry, and vascular pattern characterize the resulting image. Assertions about possible underlying malignancy are interpretations that require independent clinical confirmation.

The Functional Vascular Challenge: Both reports describe two replicate sets of three high-resolution infrared images. The second set was acquired after approximately one minute of hand immersion in cool water near 53 o F (11°C). The laboratory uses this controlled stimulus to assess adaptive changes in blood flow. Cooling challenge triggers sympathetic vasoconstriction, reducing skin blood flow and altering temperature. Comparing images before and after the challenge offers a functional observation beyond a single static thermogram.

The reports describe the cool challenge as intended to distinguish normally regulated vessels from potentially unregulated hyperemia. Nevertheless, thermal responses can be affected by autonomic variation, certain medications, ambient conditions, and acquisition technique. A response pattern is not a cancer-specific test (pathognomonic).

Report A: Persistent Asymmetric Findings - The first report compares examinations from 2020, 2022, and 2023. It describes an asymmetric, moderately hyperthermic, diffuse vascular pattern in the peri-areolar and upper right pectoral region. The laboratory identified no significant thermal signs on the opposite side. Post-challenge images nevertheless showed bilaterally symmetric adaptive attenuation of emission levels after the cool challenge, indicating that the observed asymmetry and the cooling response were considered together rather than in isolation.

The right side received TH-4 and the left TH-1 across all three study dates. The interpreter described relatively small interval changes in vascular extent, caliber, and thermal emission and considered the persistence of the pattern relevant to the assessment. The report associated the TH-4 pattern with an approximate 65% risk of malignant disease. This is the laboratory’s stated risk estimate, not a confirmed diagnosis or an independently verified probability for this individual. The report recommended further objective evaluation and a comparative restudy in 90–120 days.

Report B: Symmetrical Thermal Findings: The second report found essentially symmetrical thermal patterns across both pectoral regions, without significant focal or complex vascular asymmetries or disproportionate whole-region hyperthermia. Following the cold challenge, both sides demonstrated symmetric adaptive attenuation. The laboratory assigned TH-1 to both regions and recommended annual comparative thermology.

A critical qualification appears in this report: the images did not conform to standardized protocols. That limitation matters when interpreting the strength and reproducibility of the findings. TH-1 means no qualifying thermological signs were identified under the laboratory’s criteria; it does not rule out all chances of cancer or other breast pathology.


Inside the Reports: What the Observations Add - Selected brief excerpts show the difference between measurable findings and their clinical interpretation:

Vascular configuration — Report A, p. 2 “An asymmetric, moderately hyperthermic, diffuse and vascular pattern”

Value: documents the location and character of a surface thermal asymmetry. Limitation: cannot establish its underlying cause.

Dynamic response — Report A, p. 2  “symmetric and adaptive attenuation of the emission levels”

Value: describes physiological change following a defined stimulus, adding a second dimension to static imaging.

Longitudinal comparison — Report A, p. 2 “increases of extent, caliber and relative emission levels”

Value: records changes in image characteristics over time, although evolution is not specific to malignancy.


Normal classification — Report B, p. 1  “does not indicate any thermology Signs or Criteria”

Value: illustrates how an examination without qualifying abnormalities is categorized under this laboratory’s framework.

 



The TH Scoring System: What the Numbers Mean-  The reports reference the Marseille thermological classification system, developed in the 1970s, which grades findings from TH-1 to TH-5 using defined thermal signs and criteria. These two examples substantiate the following narrower interpretation: TH-1 denotes no qualifying concerning signs, whereas TH-4 denotes multiple signs that the laboratory considers associated with increased malignancy risk. The reports do not supply a full criterion-by-criterion definition of TH-2, TH-3, or TH-5; those categories should not be reconstructed from these examples. TH scores are similar but not exactly interchangeable with BI-RADS categories.

 

Characteristic

Report A

Report B

Right pectoral TH score

TH-4

TH-1

Left pectoral TH score

TH-1

TH-1

Thermal distribution

Asymmetric right-sided pattern

Essentially symmetrical

Post-challenge response

Adaptive attenuation

Symmetric adaptive attenuation

Temporal comparison

Three examinations

No prior comparison listed

Laboratory conclusion

Concerning thermological signs

No qualifying thermological signs


Clinical Value and Important Boundaries - These examinations demonstrate several potential documentary strengths: noninvasive measurement of skin-surface temperature, comparison between anatomical sides, observation of dynamic cooling responses, and longitudinal review of thermal patterns. They also demonstrate why interpretation must be cautious. Inflammation, infection, benign vascular processes, and acquisition variability can produce variant thermal findings that are not malignant. Conversely, an apparently normal thermal study cannot exclude a lesion.

Thermography is an US Dept HHS listed adjunctive screening modality with FDA regulated equipment but not recognized as a replacement for mammography, and evidence does not establish it as an effective standalone breast cancer screening method in men. Any palpable lump, nipple discharge, nipple inversion, skin change, or other suspicious symptom warrants clinical examination and appropriate established diagnostic imaging, commonly diagnostic mammography and/or targeted ultrasound as indicated.


Conclusion: A Responsible Role in Men’s Breast Health

Dr. Hoekstra’s contrasting reports help explain how a laboratory transforms thermal measurements into descriptive findings and TH classifications. The TH-4 case shows how persistent regional asymmetry and vascular characteristics can prompt concern and further evaluation; the bilateral TH-1 case illustrates the absence of qualifying signs within the same interpretive framework. Neither classification independently diagnoses or excludes cancer.

For men’s breast health, the principal present value of these examples is educational: they encourage attention to male chest and breast changes and show how functional observations differ from structural diagnosis. Whether standardized infrared thermology can contribute clinically useful supplementary information to male breast cancer pathways remains a research question. Awareness, timely evaluation of symptoms, and evidence-based diagnostic care must remain central.



Source and Editorial Notes
Primary sources: two anonymized reports titled “Analysis of Thoracic Thermology,” interpreted by Dr. Phil Hoekstra, DABT (2023, five pages; 2026, three pages). All patient names, dates of birth, scan identifiers, and referring clinician information have been omitted. Selected short excerpts are reproduced for critical educational commentary; original thermograms and proprietary page layouts are not reproduced.

IMAGE CREDITS & SPECIAL ACKNOWLEDGMENTS

Image Credits & Courtesy

Original clinical thermographic images, medical interpretations, and supporting diagnostic materials are the intellectual property of Therma-Scan Reference Laboratory, LLC, and are presented courtesy of Dr. Phil Hoekstra and Betsey Bowers of Bet-A-Therm Thermography. Educational illustrations and graphic adaptations are included to support public understanding of infrared thermology and men's breast health. All rights to original clinical materials remain with their respective owners.

SPECIAL THANKS- We extend our sincere appreciation to Dr. Phil Hoekstra, DABT, of Therma-Scan Reference Laboratory, LLC, for his scientific expertise, clinical interpretations, and contributions to the advancement of medical infrared thermology. His work provides the clinical foundation for this educational examination of thoracic thermal imaging and its potential relevance to men's breast health. Special recognition is also extended to Betsey Bowers, Founder of Bet-A-Therm Thermography, for her commitment to expanding access to noninvasive thermal imaging services, promoting public health education, and encouraging greater awareness of emerging and complementary physiological assessment technologies.


SPECIAL RECOGNITION OF OUR SPONSORS

Our gratitude goes to Cheri Ambrose of the Male Breast Cancer Global Alliance (MBCGA) and the National Cancer Collective (NCC) for their sponsorship and support of this educational publication. Their commitment to cancer awareness, patient advocacy, survivorship, and improved quality of life helps bring greater visibility to an often-overlooked concern: men's breast health and male breast cancer. Through collaboration among medical professionals, researchers, imaging specialists, and cancer advocacy organizations, we seek to encourage informed discussion, responsible scientific inquiry, and earlier recognition of concerning breast health symptoms among men.

This publication is intended for educational purposes. Thermography is not a substitute for established breast cancer screening or diagnostic procedures. Sponsorship and acknowledgment do not constitute endorsement of thermography as a validated standalone cancer screening method.


Medical disclaimer: This paper summarizes laboratory interpretations; it does not independently validate risk percentages, test performance claims, or clinical outcomes. Infrared thermography should not replace established breast cancer screening or diagnostic imaging.





Tuesday, January 20, 2026

TOXIN AWARENESS & DETOX PROTOCOLS

PHOTO NEWS SHOWCASE

  

NEWS REPORT

Montecito Fire Chiefs Meet With DETOXSCAN & F.A.C.E.S. Leadership to Discuss the Advancement of Toxin Awareness, Detox Protocols & Diagnostic Innovations for Firefighters

Montecito, CA — In a pivotal cross-agency meeting, DETOXSCAN Associate Editor Daniel Root and Lennard Goetze, President of F.A.C.E.S. (Firefighters Against Cancers & Exposures), convened with Fire Chief David Neels and Battalion Chief Shaun Davis of the Montecito Fire Department to address one of the most urgent crises in the modern fire service: occupational exposures and their lifelong health consequences.

Facilitated by integrative physician Dr. Leslie Valle Montoya—a clinical partner to DETOXSCAN and F.A.C.E.S. currently supporting firefighters responding to the Los Angeles wildfires—this meeting reinforced a shared mission: understanding the toxins firefighters face, implementing real detox pathways, and integrating new diagnostic tools such as point-of-care ultrasound (POCUS) and OligoScan toxin analysis.


A Shared Priority:
Occupational Exposure Is No Longer Optional - It’s a Crisis

From the outset, both agencies aligned on one reality: firefighters are exposed to an unprecedented and escalating mix of carcinogens, neurotoxins, combustion by-products, plastics, PFAS, VOCs, and heavy metals. Exposure is inevitable—but the long-term consequences don’t have to be.

Chief Neels emphasized that Montecito firefighters returning from recent wildfires—especially the Eaton and Palisades Fires—were already reporting concerns that triggered statewide attention and motivated early testing. Yet when well intended groups attempted to perform on-site blood draws at fire camps without adequate vetting, Chief Neels halted the effort for his personnel.


“It’s really tough for me… to support someone I don’t know drawing bloods at a fire camp that we have not vetted at all,” he explained. “We were not supportive. We needed to step back, bring our firefighters home, and do this properly.”  That caution marked a turning point: the department sought credible partners, validated methods and quantifiable testing—three pillars that DETOXSCAN and F.A.C.E.S. were built for.


  

Introducing Metal Scanning Innovation: OligoScan Toxin Mapping & POCUS

During the meeting, Goetze and Dr. Robert L. Bard (a brief guest participant) demonstrated the value of non-invasive toxin detection, including the OligoScan—a clinical spectrometer that scans tissue for heavy metals and elements in minutes.

 

Dr. Bard shared his own verified mercury results and explained how the device can:

·        detect metals such as mercury, lead, arsenic, and thallium,

·        quantify tissue levels rather than temporary blood or urine snapshots,

·        provide data within minutes without needles or lab shipping delays,

·        serve as a rapid screening tool after fire incidents.

For Montecito’s leadership, the possibility of on-scene or same-day toxin screening—immediately after exposure—was compelling. Equally striking was the introduction of POCUS (Point-of-Care Ultrasound), now available in handheld formats as small as a smartphone, with elastography and Doppler. POCUS is increasingly used for internal organ evaluation, inflammation mapping, and identifying toxin-related fibrosis patterns.

“This is the Star Trek future,” Goetze said, noting that modern POCUS can be used in rigs, med units, and firehouses for quick assessment and triage—without invasive procedures.


Montecito’s Key Question: “How Do We Get Toxins Out of Our Firefighters?”

Battalion Chief Shaun Davis—head of the department’s Safety Committee—cut to the central dilemma:
“We know what’s in us. We know exposure is inevitable. But what do we do about it? What actually gets it out of us?”   This question marks a national gap many fire departments face. Prevention and PPE improvements help, but they cannot remove absorbed toxins already accumulating in organs, tissues, and endocrine systems.

Davis outlined the department’s three-part approach:

1.     Prevention – minimizing exposure via PPE practices and decontamination.

2.     Post-incident Decon – showers, gear isolation, and cleaning protocols.

3.     Post-exposure Treatment – the missing puzzle piece: effective detox methods that work.

 

This is where DETOXSCAN and its encyclopedic toxicology database offered what Davis called “the next piece we’ve been missing.” The DETOXSCAN.org platform catalogs:

·        known environmental and occupational toxins,

·        scientifically supported detox modalities,

·        clinical technologies,

·        global protocols including niacin-induced detoxification, sauna-based programs, and integrative methods.

Root explained how DETOXSCAN’s evidence-driven framework aligns with F.A.C.E.S.’ core mission: prevention, early detection, and real-world recovery solutions for firefighters.

 

The Evidence Firefighters Need: Real Detoxification in Action

To answer Davis’s question about what actually removes toxins, Root presented dramatic evidence from the Root Method detox program: A New York narcotics officer who had conducted over 200 meth-lab raids sweated out visible chemical compounds during sauna-based detox sessions—enough to discolor towels in vibrant patterns confirmed as residues such as sodium hydroxide (Drāno). “These are the kinds of toxins inside the body that can come out,” Root explained.

Firefighters in wildfire regions, meth-lab response, hazmat incidents, and structure fires experience similar exposures, making such detox outcomes directly relevant. Although Montecito firefighters are currently undergoing a Level 1 detox program at Dr. Montoya’s clinic, Root noted the availability of a Level 3 full 30-day detox protocol—a complete mobilization-and-elimination methodology used for decades in occupational medicine.


Building A Local Framework: Montecito Fire Positions Itself as a First-Mover

Chief Neels emphasized the advantage of being a Fire District—which grants him greater administrative flexibility and the authority to implement innovative programs quickly. “We can pivot and we can make things happen here,” he affirmed.


 

The department’s next steps, as outlined by Neels and Davis, include:

·        reviewing feedback from the six firefighters currently participating in Dr. Montoya’s program,

·        evaluating the potential integration of OligoScan and POCUS,

·        expanding education on exposure risks and detox solutions,

·        coordinating with the department’s medical director and national experts like Dr. Jeff Burgess (Firefighter Cancer Cohort Study).

Neels also requested further information, reports, and case studies on OligoScan accuracy and adoption in U.S. and international fire departments.


A Collaborative Future: Firefighters Deserve Options—And Proof

The meeting concluded with a shared commitment to collaboration, transparency, and scientific rigor. Goetze emphasized that every article, newsletter segment, and educational publish will be fully approved by the department before release. “We just want to save lives—just like you do,” he said. “Whatever you need, we are here.”

Chief Neels reciprocated, noting the value of having partners who can bring credible, vetted solutions to the table. Davis expressed eagerness to connect further with Root to align detox strategies with emerging national research. In a field where cancer remains the #1 killer of firefighters, Montecito Fire’s proactive stance—and the partnership with DETOXSCAN, F.A.C.E.S., and Dr. Leslie Valle Montoya—marks a powerful shift toward a new model: measurement, mitigation, detoxification, and early detection.

This meeting represents a landmark step in redefining firefighter health protection for the next generation.




 SUPPLEMENTAL NEWS:

The Next Battle in Occupational Exposure: Detecting and Mitigating Heavy Metals

By: Dr. Robert L. Bard

I have spent years scanning for cancer—breast, thyroid, prostate, liver, lymphatic disease—and for inflammatory conditions that often precede malignancy. In that process, I have met hundreds of first responders who did everything right on the job, yet were never warned about the long-term biological cost of service. What has become increasingly clear to me—especially over the past year—is that heavy metal toxicity is the next sensible, unavoidable frontier in occupational medicine.

Through the growth and application of DetoxScan.org, we have been able to evaluate individuals who appear “clinically normal” on the surface, yet demonstrate alarming internal burdens of mercury, lead, cadmium, arsenic, aluminum, and other metals. These findings are not isolated. They are patterned. And they correlate strongly with occupational exposure narratives I hear every day.

From Camp Lejeune veterans exposed to contaminated water, to burn-pit exposure in Iraq and Afghanistan, to Vietnam-era Agent Orange, to firefighters working plastics-heavy modern fires and Ground Zero responders from 9/11—one recurring pathogenic thread emerges: metals that accumulate silently and persist for decades.

Heavy metals are not benign. They are neurotoxins, endocrine disruptors, mitochondrial poisons, and immune modulators. Clinically, they are associated with chronic fatigue, cognitive decline, tremors, neuropathy, thyroid dysfunction, cardiovascular disease, autoimmune disorders, infertility, mood disturbances, and increased cancer susceptibility. These are not abstract theories—they are findings we see repeatedly when exposure history is paired with modern screening.

What has changed—and what gives me great optimism—is access to non-invasive screening technologies, including spectrophotometry and light-based tissue analysis. These tools allow us to assess metal burden safely, rapidly, and without radiation or invasive sampling. When paired with diagnostic imaging, laboratory studies, and clinical history, they expand our investigative lens dramatically.

As a self-described cancer detective, I can say this plainly: these technologies don’t just give us answers—they teach us which questions to ask next. They help connect unexplained inflammation, metabolic dysfunction, and neurological symptoms to tangible, measurable causes.

Early cancer detection saved countless lives. I believe early toxic burden detection will do the same. If we truly want to protect those who protect us, this is the battle we must now fight—with vigilance, intelligence, and better tools than ever before.



SEE COMPLETE FEATURE

Friday, December 19, 2025

WHEN THE SMOKE NEVER CLEARS: A DOWNED RESPONDER'S PLIGHT WITH CO POISIONING

Marissa’s Story and the Hidden Epidemic: Understanding the Neurotoxins Behind the Fog

By: Lennard M. Goetze

Photo courtesy: FF Marissa Halbeisen
Across the country, thousands of first responders and civilians are living with an invisible illness—neurological damage linked to smoke inhalation and carbon monoxide (CO) exposure. Often mistaken for stress, depression, or simple fatigue, this condition silently erodes cognitive function, emotional regulation, and physical stability. Modern fires, fueled by plastics, synthetics, building materials, vehicles, and batteries, release a toxic brew of gases, heavy metals, and particulates. Among these, carbon monoxide remains the most underestimated threat.

CO binds to hemoglobin more than 200 times stronger than oxygen. Even small exposures can deprive the brain of oxygen long enough to trigger acute injury. But for many, the greater danger comes later. Delayed Neurological Sequelae (DNS)—a progressive neurological decline occurring weeks or months after exposure—often goes unrecognized, untested, and untreated.

This is the unseen battlefield Marissa Halbeisen, a veteran firefighter, stepped into after a wildfire response that changed her life. Her story is not an outlier—it is a warning.


The Night Everything Changed

Marissa had survived two decades of fires, rescues, and high-risk deployments. But in January, during a wind-driven Los Angeles wildfire, she encountered a hazard she couldn’t see. Working through hurricane-force winds, sandblasted eyes, and suffocating smoke, she made a choice many engineers make on wildfire operations: she saved the limited air supply for the nozzle teams. She stayed in the smoke.

“It wasn’t the flames that nearly took me out... the smoke I couldn’t see almost did.”

By the time the fire crossed the highway, her head was pounding, her vision blurred, and her breathing felt labored. She assumed it was exhaustion—an unavoidable part of the job. She didn’t know the true injury was already unfolding inside her brain.

 

The Descent Into the Invisible Injury

In the weeks that followed, Marissa began experiencing symptoms that alarmed her: mental fog, slowed processing, and memory problems. Tasks she once performed effortlessly suddenly felt foreign. Teaching at the fire academy became difficult. Studying for her captain’s exam—material she knew cold—was impossibly hard. “I looked fine on the outside. Inside, it felt like someone unplugged my brain.”

By April, her once-rigorous workouts stopped. By May, she pulled herself off duty—a decision firefighters rarely make without extreme cause. She underwent blood tests, autoimmune panels, imaging, and routine assessments. Everything came back “normal.”

But nothing was normal.  She developed overwhelming fatigue, full-body aches, slurred speech, and balance problems. At her worst, she could not drive. “It felt like being intoxicated all the time without having touched a drink,” she said.

An ER visit revealed nothing on standard tests. Yet deeper investigation finally uncovered the truth: hypoxic brain injury linked to CO exposure. MRI imaging, a toxicology assessment, and evaluations by occupational medicine specialists revealed she had experienced significant carbon monoxide poisoning—followed by delayed neurological decline.

She was left with the classic signs of DNS: cognitive impairment, motor coordination issues, hormonal disruption, and chronic neuroinflammation.


The System Misses What It Cannot See

Marissa’s ordeal highlights a troubling reality: CO injuries are wildly underdiagnosed, especially among firefighters. Wildland operations, unlike structure fires, often lack formal rehab protocols or CO monitoring. Firefighters frequently operate in heavy smoke without SCBA, believing the risk is acceptable or temporary. The consequences can be catastrophic. Research shows that mild to moderate CO exposure can trigger:

• Memory loss and slowed processing

• Personality changes and irritability

• Balance and gait disturbances

• Hormonal dysregulation

• Autonomic nervous system impairment

• Increased risk for long-term neurodegenerative disease

Yet because CO clears from the blood within hours, by the time a firefighter seeks help, measurable evidence has vanished. Only MRI, neurocognitive testing, and clinical experience reveal what the bloodstream no longer does. “They told me my tests were normal. My body was telling me I was drowning.”

Marissa’s experience reflects the silent epidemic affecting many firefighters, veterans, athletes, and civilians exposed to toxic air.

 

Finding a New Model of Care

When traditional medicine failed to explain her symptoms, Marissa found a different path through Dr. Leslie Valle-Montoya and the Brainwave Wellness Institute—an organization dedicated to non-invasive brain performance therapies and recovery from toxic exposures.

Dr. Valle-Montoya conducted deeper diagnostic testing, including mineral and heavy metal screening, autonomic assessments, and inflammatory mapping. The results confirmed what Marissa felt: her body was carrying a toxic burden, and her nervous system was in distress.



Treatment included:

• Mild hyperbaric therapy to improve oxygenation

• Ozone nebulization to clear the mucus membranes damaged by smoke

• Bioenergetic frequency therapy to support detox and brain recovery

• Niacin-assisted sauna detoxification

• Nutrition protocols and hormone-balancing strategies

Within weeks, Marissa noticed sparks of improvement. Her clarity brightened. Her energy rose. She still faced challenges—but now she finally had a plan.


________________________________________

A Broader Crisis: Many Suffer in Silence

Marissa’s story echoes across the fire service. For every firefighter diagnosed, many more quietly struggle. Symptoms like irritability, “forgetfulness,” trouble concentrating, unexplained fatigue, or emotional volatility are often written off as stress. Departments lack consistent monitoring, education, or long-term tracking of neurological symptoms.

The truth is stark: CO poisoning and neurotoxic smoke exposure may be one of the most overlooked occupational diseases of modern firefighting. Organizations such as the Brain Injury Alliance, Carbon Monoxide Safety groups, IAFF wellness programs, and emerging CO survivor networks are beginning to push awareness forward. But most sufferers still remain undiagnosed—soldiers in a silent war against toxins that do not show up on standard lab panels.

________________________________________

Marissa’s Mission: Turning Injury Into Advocacy

Despite ongoing recovery, Marissa’s spirit remains anchored in service. She refuses to let this invisible injury silence her. Instead, it has sharpened her purpose. “If I make it back, I’m coming back better than before—and I’m taking others with me.”

She now hopes to educate firefighters on early detection, advocate for CO monitoring protocols, and support national organizations fighting for recognition of toxic exposure injuries. Her story represents both a warning and a roadmap—proof that invisible injuries are no less devastating, and no less deserving of care.

________________________________________

A Call to Action

Marissa’s experience makes one thing clear: the fire service must evolve.

• CO monitoring must become standard.

• Rehab must be mandatory on wildland incidents.

• Neurological screening must be built into occupational health.

• Firefighters must be taught to recognize—not hide—signs of cognitive decline.

For every Marissa who speaks out, dozens remain unheard. This newsletter—and this story—is for them.

Because the smoke may clear from the hillside, but for many, it lingers in the brain long after the fire is gone.



Tuesday, September 30, 2025

Dr. Letitia’s Comprehensive Approach to Healing

 Detox as the Missing Link

From an exclusive interview with DetoxScan News editors

For Dr. Letitia, detoxification is far more than a wellness trend. It is the critical missing link in understanding why so many patients are struggle with chronic illness, fatigue, neurological decline, and immune dysfunction. In her clinical work, she sees detox as the foundation of recovery—a systematic way to identify and reduce toxic burdens that sabotage the body’s capacity to heal.

Her philosophy combines advanced diagnostic testing, nutritional strategies, targeted therapeutics, and a stepwise approach that ensures patients can safely mobilize and eliminate toxins. At the heart of her message lies a conviction: treating the root cause of inflammation and toxic load can restore vitality even in complex, long-standing conditions.


Inflammation: The Starting Point: “First, eliminate whatever contributes to inflammation because that’s going to impact your immune system and your nerves,” Dr. Letitia emphasizes. Chronic inflammation is both a cause and a consequence of toxin exposure. Left unchecked, it suppresses immunity, impairs nerve regeneration, and sets the stage for viral reactivation, neurodegenerative disease, and progressive decline.

Rather than focusing on symptoms alone, she identifies upstream drivers: environmental toxins, hidden infections, heavy metals, and mold. Only by removing these roadblocks can patients regain balance.



The Overlooked Role of Viruses: In many of her patients, viral reactivation becomes the tipping point. Polio, Epstein-Barr, herpes viruses, or even post-COVID complications resurface when the immune system is weakened by toxic exposures. Antivirals may reduce symptoms temporarily, but they do not address the root immune dysfunction.

I don’t really think this expresses my views. Try this:

In many of her patients, viral reactivation may occur due to the infectious and toxic burden further compromising the immune system. While antivirals may help, addressing the root causes of the immune burden and dysfunction is not only necessary but is often sufficient in addressing viral reactivation.

Dr. Letitia relies on advanced tools such as:

  • Cyrex panels to evaluate immune dysregulation. I actually don’t use this panel.
  • Dr. Bruce Patterson’s cytokine panel by Radiance Lab which can identify the chronic inflammatory response resulting from COVID, vector-borne diseases and viral reactivation, differentiating the drivers of inflammation and immune compromise. By identifying what is actually driving immune suppression, she can tailor detox and treatment strategies accordingly.

Heavy Metals: The Hidden Burden: Another cornerstone of her work is heavy metal detoxification. Many patients unknowingly carry a body burden of metals such as lead, mercury, cadmium, or aluminum from environmental exposure. Medical implants, dental appliances and amalgams can further burden immune and detox capacities.

  • Titanium implants may trigger allergic or inflammatory reactions; specialized testing helps determine sensitivity.
  • Urine provocation testing with agents like DMPS or DMFA provides the most accurate measure of total metal load.
  • Lead toxicity remains rampant, especially in those born before 1978, as aging bones release stored lead back into circulation—fueling cardiovascular disease and cognitive decline.
  • Mercury accumulates in kidneys and brain tissue, impairing neurological and metabolic function.

Her golden rule: By treating the underlying factors that are compromising detox, such as mold, heavy metal chelation will be better tolerated and more effective.  If detox pathways are blocked, mobilizing metals too early can overwhelm the system and worsen symptoms.


Mold and Mycotoxins: The Central Disruptor: If there is one toxin Dr. Letitia sees as the great disruptor, it is mold. More than an allergy issue, mold produces mycotoxins that directly damage nerves, suppress vascular repair, alter sleep patterns, compromises the immune system, disrupts metabolism and throw hormones into chaos.

Mold patients often experience:

  • Post-exertional crashes, where exercise leaves them weaker instead of stronger.
  • Impaired blood vessel regeneration due to VEGF suppression.
  • Shifts from efficient Krebs cycle metabolism into the less efficient Cori cycle, leading to energy depletion.
  • Sleep disturbances, hormone imbalance, and cognitive symptoms such as brain fog and memory issues.

Testing for Mold

She uses a two-tier diagnostic strategy to validate her symptom-based clinical diagnosis:

  1. Visual Contrast Sensitivity (VCS) Test — a quick, accessible online screening tool that assesses optic nerve neurotoxic impact by nutrition, mold, Lyme and high mercury.
  2. Urine mycotoxin testing —usually provoked with liposomal glutathione to mobilize stored toxins.  She typically prescribes Pure Encapsulations glutathione, taken twice daily for six days before urine collection.

The results guide binder selection, since different mycotoxins require different binding agents for elimination. Over time, as detox pathways open, patients tolerate binders better as detox pathways become more efficient.


Therapeutic Detox Tools: Dr. Dr. Letitia’s detox approach integrates biochemical, nutritional, and supportive therapies:
  • Glutathione: The body’s master antioxidant, essential for mobilizing toxins.
  • Binders: Tailored to specific mycotoxins based on test results.
  • Peptides and bioregulators: Support nerve and muscle regeneration.
  • Nutritional support: Adequate protein (at least 60 g daily for seniors), creatine supplementation, and anti-inflammatory diets to rebuild strength and resilience.
  • Neural limbic and Vagal nerve support
  • Hormonal support (e.g. thyroid, estrogen, testosterone, progesterone)

She stresses the importance of sequencing:

  1. Treatment of Mast Cell Activation if present to allow progress and increase tolerance of treatments
  2. Mold detox to unblock pathways and decrease toxic burden.
  3. Treatment of vector-borne diseases (e.g. Lyme, Bartonella, Babesia).
  4. Heavy metal detox, once the body can safely process them.

Nutrition as Detox Medicine: Beyond testing and supplements, diet remains central. Inspired by the work of Dr. Terry Wahls, who reversed her multiple sclerosis symptoms through a nutrient-dense, anti-inflammatory diet, Dr. Letitia applies similar principles.

She puts all new patients on an anti-inflammatory eating plan for the first 5–6 weeks. By the time they return, she often sees 40–60% improvement—before any targeted detox begins. For her, this confirms that nutrition is medicine, not just maintenance.



Clinical Mentorship and Proven Protocols: Dr. Letitia follows the protocols of Dr. Neil Nathan, a pioneer in mold and toxin illness treatment. His book Toxic and his mentorship group of ~200 practitioners worldwide provide frameworks for safe and effective detox care.

His emphasis on individualized treatment for “sensitive patients” has shaped her own approach—ensuring detox is tailored, not one-size-fits-all. This specialized expertise underscores why so few practitioners worldwide can manage mycotoxin illness at this level.



Practical Advice for Patients

Patients under Dr. Letitia’s care can expect a stepwise journey:

  1. Initial diet shift: Anti-inflammatory, nutrient-dense foods.
  2. Screening tests: VCS for neurotoxin effects; advanced panels for immune and cytokine mapping.
  3. Definitive toxin testing: Urine mycotoxin analysis.
  4. Detox mobilization: binders
  5. Antifungal treatment
  6. Sequenced toxin elimination: Often mold first, infections next, metals last—but individualized for each patient.

She advises patients to remain patient with the process, as mobilizing toxins can temporarily worsen symptoms before improvements are felt. Over time, however, detox can yield profound transformations—even reversing conditions once thought irreversible.


Conclusion

Dr. Letitia’s view of detox is both holistic and rigorously scientific. She sees it not as an optional add-on, but as the essential foundation for healing chronic illness. By unmasking hidden burdens—mold, metals, viruses, infections—and safely eliminating them, she helps patients reclaim their health, strength, and resilience.

Her clinical wisdom is anchored in science but applied with compassion. For patients caught in cycles of decline, detox is more than a treatment—it is a pathway back to life.

 



 

HONORING THE VOICE OF DIAGNOSTIC EVOLUTION
by Dr. Robert L. Bard

In my decades of medical imaging, I’ve come to recognize the rare few who carry a visionary spark—those who not only question outdated systems but boldly chart new paths for healing. Dr. Letitia is one of those rare voices. Her paper doesn’t just present a “functional” approach to medicine; it represents a paradigm shift that honors complexity, individuality, and the silent clues the body gives long before disease declares itself.

What resonates most with me is her insistence on connecting root causes rather than chasing symptoms. This is the future of diagnostics—and one I’ve fought for across cancer care and inflammatory disease. Her lens, rooted in functional medicine, is precisely what our diagnostic world needs: an integrative framework that embraces bio-individuality, toxin exposure, immune dysregulation, and endocrine disruption—not in silos, but as interwoven parts of the same story.

In cancer detection and inflammatory disease, where time is the greatest enemy, Dr. Letitia’s thinking aligns with what I advocate daily through advanced ultrasound, Doppler studies, thermography, and elastography. The body's vascular response, its inflammatory activity, and its metabolic burden can all be measured—if we’re looking in the right ways. Her call for deeper, data-informed care echoes the mission of our most progressive imaging efforts.

It takes courage to break away from the allopathic assumptions that have become comfortable for too many. Dr. Letitia does so with elegance and clinical integrity. She empowers both the patient and the practitioner to step into a more accountable role—to ask harder questions and pursue more meaningful answers.

As we continue our journey toward early detection, prevention, and true root-cause medicine, voices like hers must be elevated. Her commitment to precision diagnostics as a pillar of wellness—and not just disease care—places her squarely in the vanguard of our next generation of healers.

I stand in full support of her work and invite others in the diagnostic and oncology fields to listen closely. She’s not just challenging the system. She’s upgrading it.

 







Copyright Notice
This article is an original work produced by the writing and editorial team of the AngioInstitute (a 501(c)(3) nonprofit organization), created exclusively for use, distribution, and publication by AngioMedical News, HEALTHTECHREPORTER.com and its subsidiaries. All content contained herein, including written material, concepts, titles, and formatting, is the intellectual property of the AngioInstitute and is protected under United States and international copyright laws. Unauthorized reproduction, copying, distribution, transmission, or republication of any portion of this material—whether in print, digital, or any other format—is strictly prohibited without prior written permission from the copyright holder. The AngioInstitute retains full ownership of the content until and unless formally transferred in writing. This draft may not be altered, adapted, or used in derivative works without express consent. All rights reserved. For inquiries regarding usage, permissions, or content licensing, please contact the AngioInstitute directly.

MEN'S HEALTH: Thermal Imaging of the Chest

The Science and Clinical Interpretation of Thoracic Infrared Thermology Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment,...